Literature DB >> 28370446

Addressing the Crisis in the Treatment of Osteoporosis: Better Paths Forward.

William V Stoecker1,2, Aaron Carson2, Vu H Nguyen2, Alex B Willis3, Justin G Cole4, Ryan K Rader1,2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28370446     DOI： 10.1002/jbmr.3145

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  4 in total

1.  Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.

Authors:  S L Solimeo; V-T T Nguyen; S W Edmonds; Y Lou; D W Roblin; K G Saag; P Cram; F D Wolinsky
Journal:  Osteoporos Int       Date:  2019-01-30       Impact factor: 4.507

2.  18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.

Authors:  Xiao Chen; Xin Zhi; Zhifeng Yin; Xiaoqun Li; Longjuan Qin; Zili Qiu; Jiacan Su
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

3.  Magnolol prevents ovariectomy‑induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor‑κB and mitogen‑activated protein kinase pathways.

Authors:  Wen-Yong Fei; Qiang Huo; Pei-Qing Zhao; Long-Juan Qin; Tao Li
Journal:  Int J Mol Med       Date:  2019-02-18       Impact factor: 4.101

4.  Factors Associated With Osteoporosis Care of Men Hospitalized for Hip Fracture: A Retrospective Cohort Study.

Authors:  Samantha L Solimeo; Kimberly McCoy; Heather Schacht Reisinger; Robert A Adler; Mary Vaughan Sarrazin
Journal:  JBMR Plus       Date:  2019-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.